This study is designed to compare the efficacy of detection of COVID-19 infection using the serology test in blood sample and the PCR-based test in the nasopharyngeal (NP) and sputum sample. Furthermore, it aims to evaluate the temporal trend of appearance of IgM and IgG in blood.
The investigators hypothesize that viral-RNA test using sputum will be equally efficient as
the test performed in NP swab. Moreover, the serology test and the PCR-based test will be
comparable in efficacy for detection of infection
Diagnostic Test: diagnostic tests for COVID-19 infection
Compare the efficacy of diagnostic tests for COVID-19 infection in detecting antibodies and viral-RNA
Inclusion Criteria:
- • Male or female over 18 years of age at the time of enrollment
- Current symptoms of COVID-19 ; fever alone or fever and at least one of the
following symptoms need to be present
- Dry cough
- Sore throat
- Shortness of breath
- Chills
- Muscle pain
- Headache
- New loss of taste or smell
- Chills with repeated shaking
Exclusion Criteria:
- • Unwilling to provide informed consent
- Unwilling to undergo bi-weekly serological test during the 1-month enrollment
Texas Cardiac Arrhythmia Institute
Austin, Texas, United States
Investigator: Mitra Mohanty, MD
Contact: 512-544-8186
mitra1989@gmail.com
MITRA Mohanty, MD
5127842651
mitra1989@gmail.com
Deb Cardinal, RN MBA
512) 807-3150